Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)

ClinicalTrials.gov ID: NCT00264797

Public ClinicalTrials.gov record NCT00264797. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 2:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Controlled Trial of Osmotic-Release Methylphenidate (OROS-MPH) for Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents With Substance Use Disorders (SUD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the efficacy of osmotic-release methylphenidate (OROS-MPH) versus placebo for the treatment of ADHD in adolescents with SUD.

Study identification

NCT ID
NCT00264797
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
University of Cincinnati
Other
Enrollment
303 participants

Conditions and interventions

Eligibility (public fields only)

Age range
13 Years to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2006
Primary completion
Sep 30, 2008
Completion
Sep 30, 2008
Last update posted
Jun 6, 2013

2006 – 2008

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
12
Facility City State ZIP Site status
Synergy Treatment Center Denver Colorado 80219
Gateway Community Services Jacksonville Florida 32211
Operation PAR, Inc. St. Petersburg Florida 33709
Mountain Manor Treatment Programs Baltimore Maryland 21229
SSTAR: Stanley Street Treatment & Resources, Inc Fall River Massachusetts 02720-6009
Crittenton Kansas City Missouri 64134
St. Luke's-Roosevelt Hospital, Child and Family Institute New York New York 10025
Rehab After Work-Life Counseling Services Paoli Pennsylvania 19301
Addiction Medicine Services Pittsburgh Pennsylvania 15213
SSTAR of Rhode Island North Kingstown Rhode Island 02852
LRADAC Columbia South Carolina 29205
Mental Health and Retardation of Tarrant County Fort Worth Texas 76107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00264797, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 6, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00264797 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →